Sub menu

Day: March 1, 2012

Finally, some good news for Alimera (and pSivida). A few days ago, the company announced that it had received a positive outcome to the Decentralized Procedure (DCP) for Iluvien in Europe. Iluvien is now expected to be the first sustained release pharm…

Targeting the emergent field of hyperspectral retinal imaging, Photon etc. is proud to launch IRIS™, a new device for non-invasive localization of biomolecules in the eye fundus. Based on a custom-made mydriatic retinal camera and Photon etc.’s Tun…

As the number of intravitreal injection procedures increases, so will the incidence of injection-related complications, such as endophthalmitis. Attempting to reduce the rate of postinjection endophthalmitis with prophylactic antibiotics is unnecessary…

Treating blindness caused by burns using limbal stem cells harvested from the undamaged eye of the same patient has now become cheaper, easier and safer. Results of a pilot study of the SLET (simplified technique of limbal transplantation) technique co…

At the World Ophthalmology Congress held in late February in Abu Dhabi, a small study indicated that early intervention using low-vision aids can greatly reduce the severity of depression related to vision loss in patients with age-related macular degeneration (AMD). The study was led by Susanne Trauzettel-Klosinski, MD, from the Low Vision Clinic and Research […]

RUB researchers explain channelrhodopsin Controlling nerve cells with the aid of light: this is made possible by optogenetics. It enables, for example, the investigation of neurobiological processes with unprecedented spatial and temporal precision….